Prevention of recurrent urinary tract infections

Minerva Urologica e Nefrologica

Volumn 65, Issue 1, 2013, Pages 9-20

  Wagenlehner, F M E ^a   Vahlensieck, W ^b   Bauer, H W ^c   Weidner, W ^a   Piechota, H J ^d   Naber, K G ^e  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Hospital for Rehabilitation Wildetal   (Germany)

^c Practice   (Germany)

^d KLINIKUM MINDEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibiotic prophylaxis; Immunization; Urinary tract infections

Indexed keywords

CEFALEXIN; CIPROFLOXACIN; COTRIMOXAZOLE; ESTRIOL; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; METHENAMINE; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; TRIMETHOPRIM;

ACIDIFICATION; ANTIBIOSIS; ANTIBIOTIC PROPHYLAXIS; BACTERIURIA; CATHETER INFECTION; COUNSELING; DISINFECTION; EMERGENCY CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; IMMUNOPROPHYLAXIS; INTESTINE FLORA; POSTMENOPAUSE; RECURRENT URINARY TRACT INFECTION; REVIEW; RISK FACTOR; SEXUAL INTERCOURSE; URINARY TRACT INFECTION; VAGINA FLORA;

ADJUVANTS, IMMUNOLOGIC; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CATHETER-RELATED INFECTIONS; COITUS; DIURETICS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYGIENE; INTESTINES; MALE; PHYTOTHERAPY; PROBIOTICS; RECURRENCE; RISK FACTORS; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; VAGINA;

EID: 84878756604     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Ludwig M, Hoyme U, Weidner W. [Recurrent urinary tract infection in women. Long-term antibiotic prophylaxis]. Urologe A 2006;45:436-42.
2. Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011;52:23-30.
3. Hooton TM. Prevention of recurrent urogenital tract infections in adult women. In: Naber KG SA, Heyns CF, Matsumoto T, Shoskes DA, Bjerklund Johansen TE, editors. Urogenital Infections. Arnhem, The Netherlands: European Association of Urology and International Consultation in Urological Diseases; 2010. p. 236-9.
4. Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis 2004;4:631-5. (Pubitemid 39296837)
5. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, Karpman D, Andersson B, Svanborg C. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007;195:1227-34. (Pubitemid 46543457)
6. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-68. (Pubitemid 32288741)
7. Moore EE, Hawes SE, Scholes D, Boyko EJ, Hughes JP, Fihn SD. Sexual intercourse and risk of symptomatic urinary tract infection in post-menopausal women. J Gen Intern Med 2008;23:595-9.
8. Vahlensieck W, Bauer H-W, Hoyme UB, Ludwig M, Naber KG, Wagenlehner F et al. Prophylaxe rezidivierender Harnwegsinfektionen (rHWI). Nieren- und Hochdruckkrankheiten. 2007;36:501-13.
9. Vahlensieck W, Bauer HW. Vorbeugende Therapie chronisch rezidivierender Harnwegsinfektionen (rHWI). Med Welt 2012;63:185-90.
10. O'Grady F, Cattell WR. Kinetics of urinary tract infection. II. The bladder. Br J Urol 1966;38:156-62.
11. Kunin CM. Urinary tract infections. Detection, prevention, and management. 5th ed. Baltimore, Maryland, USA: Williams & Wilkins; 1997.
12. De Paepe H, Hoebeke P, Renson C, Van Laecke E, Raes A, Van Hoecke E et al. Pelvic-floor therapy in girls with recurrent urinary tract infections and dysfunctional voiding. Br J Urol 1998;81(Suppl 3):109-13.
13. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000;30:152-6. (Pubitemid 30067073)
14. Li Y, Qu H, Xiang Q, Su Z, Huang Y. Overview on the recent study of Antimicrobial peptides: origins, functions, relative mechanisms and application. Peptides 2012 [Epub ahead of print].
15. Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, Jonasson AF et al. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS One 2010;5:e15580.
16. Glaser R, Harder J, Lange H, Bartels J, Christophers E, Schroder JM. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 2005;6:57-64. (Pubitemid 40136696)
17. Grabe M, Bjerklund Johansen TE, Botto H, Cek M, Naber KG, Tenke P, Wagenlehner FME. Guidelines on urological infections. In: Urology EAo, editor. European Association of Urology guidelines. Arnhem, Netherlands: European Association of Urology; 2011. p. 1-112.
18. Linnebur SA, Parnes BL. Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment. Ann Pharmacother 2004;38:612-6. (Pubitemid 38352225)
19. Afssaps AFdSSdPdSLapds. Nitrofurantoïne, risque de survenue d'effets indésirables graves lors de traitements prolongés 2011 [cited 2012 December]. Available at: www.infectiologie.com/site/medias/-documents/ consensus/lp-110311-Nitrofurantoine.pdf
20. Wagenlehner FME, Schmiemann G, Hoyme U, Fünfstück R, Hummers-Pradier E, Kaase M et al. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. S-3 Leitlinie der Arbeitsgemeinschaft Wissenschaftlicher Medizinischer Fachgesellschaften (AWMF) AWMF-Register-Nr 043/044 2010 [cited 2010 October]. Available at: http://www.uni-duesseldorf.de/ AWMF/
21. Stamey TA, Condy M. The diffusion and concentration of trimethoprim in human vaginal fluid. J Infect Dis 1975;131:261-6.
22. Vahlensieck W. Prophylaxemaßnahmen bei rezidivierenden Harnwegsinfektionen. In: Hofstetter A, editor. Urogenitale Infektionen. Berlin, Heidelberg, New York: Springer; 1999. p. 215-39.
23. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000;182:1177-82.
24. Preiksaitis JK, Thompson L, Harding GK, Marrie TJ. Hoban S, Ronald AR. A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceae. J Infect Dis 1981;143:603-8. (Pubitemid 11111274)
25. Melekos MD, Asbach HW, Gerharz E, Zarakovitis IE, Weingaertner K, Naber KG. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol 1997;157:935-9. (Pubitemid 27066282)
26. Mozdzan M, Loba J, Ruxer J, Markuszewski L. [Fosfomycin in the treatment of recurrent tract infections in type 2 diabetic patients]. Pol Arch Med Wewn 2006;115:219-26.
27. Ruxer J, Mozdzan M, Siejka A, Loba J, Markuszewski L. Fosfomycin and nitrofurantoin in the treatment of recurrent urinary tract infections in thype 2 diabetic women: a preliminary report. Diabetologia Doswiadczalna I Kliniczna 2006;6:277-82.
28. Albert X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004;(3):CD001209.
29. Harding GK, Zhanel GG, Nicolle LE, Cheang M. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002;347:1576-83. (Pubitemid 35315838)
30. Cai T, Mazzoli S, Mondaini N, Meacci F, Nesi G, D'Elia C et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? Clin Infect Dis 2012 [Epub ahead of print].
31. Lee B, Bhuta T, Craig J, Simpson J. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2002;(1):CD003265.
32. Larsson B, Jonasson, A., Fianu, S. Prophylactic effect of UVA-E in women with recurrent cystitis: a preliminary report. Curr Ther Res 1993;53:441-3. (Pubitemid 23234703)
33. Raz R, Stamm W. Optimal treatment of UTI in post-menopausal women. J Am Med Dir Assoc 2000;1:172-4.
34. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;(1):CD001321.
35. Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2004;(2):CD001321.
36. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011;171:1270-8.
37. Wang CH, Fang CC, Chen NC, Liu SS, Yu PH, Wu TY et al. Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012;172:988-96.
38. Dudar IO, Loboda OM, Krot VF, Khimich VI, Kryzhanivska VM, Bryzhachenko TP. 12-month comparative study of administration of Canephron® N in the treatment of patients with the urinary tract infection. Health of Man, Ukraine 2009;3:85-90.
39. Ivanov DD, Nazarenko VI, Kushnirenko SV, Krot VF, Taran EI. Therapeutic abilities of Canephron N preparation in the treatment of urinal tract infections in patients with metabolic syndrome. Health of the Ukraine 2005;17:46-7.
40. Fuenfstuc R, Straube E, Schildbach O, Tietz U. [Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection]. Med Klin (Munich) 1997;92:574-81.
41. Günther M, Noll F, Nützel R, Gläser E, Kramer G, Stöhrer M. Harnwegsinfektprophylaxe. Urologe [B] 2002;42:218-20.
42. Hernandez JG, Sunden F, Connolly J, Svanborg C, Wullt B. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 2011;6:e28289.
43. Riedasch G, Möhring K. Immunisierungstherapie rezidivierender Harnwegsinfekte der Frau. Therapiewoche 1986;10:896-900.
44. Riedasch G, Möhring K. Harnwegsinfektionen bei Kindern. Immuntherapeutikum beugt Rezidiven vor. AP Urol Nephrol 1998;10:345-6. (Pubitemid 28479912)
45. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005;115:2914-23. (Pubitemid 41434419)
46. Schmidhammer S, Ramoner R, Holtl L, Bartsch G, Thurnher M, Zelle-Rieser C. An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. Urology 2002;60:521-6. (Pubitemid 35292197)
47. Bauer HW, Rahlfs VW, Lauener PA, Blessmann GS. Prevention of recurrent urinary tract infections with immuno-active E. coli fractions: a meta-analysis of five placebo-controlled double-blind studies. Int J Antimicrob Agents 2002;19:451-6. (Pubitemid 34831646)
48. Naber KG, Cho YH, Matsumoto T, Schaeffer AJ. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009;33:111-9.
49. Bonilla-Musoles F PG, Sampaio M, Simon C, Fernandes H, Matallin P, Blanes J. Harnwegsinfekte bei der Frau - Therapie mit einem neuen Immunmodulator. TherapieWoche Schweiz 1991;12:3-8.
50. Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 2003;170:867-9. (Pubitemid 36999578)
51. Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003;36:1362-8. (Pubitemid 36702868)
52. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6. (Pubitemid 23262529)
53. Raz R. Urinary tract infections in postmenopausal women. In: Naber KG, Schaeffer AJ, Heyns CF, Matsumoto T, Shoskes DA, Bjerklund-Johansen TE, editors. Urogenital Infections International Consultation on Urological Diseases and European Association of Urology. Arnhem, The Netherlands; 2010. p. 225-34.
54. Caudieux P, Reid G. Probiotics for the prophylaxis of uncomplicated recurrent urinary tract infections in females. In: Naber KG, Schaeffer AJ, Heyns CF, Matsumoto T, Shoskes DA, Bjerklund-Johansen TE, editors. Urogenital Infections International Consultation on Urological Diseases and European Association of Urology. Arnhem, The Netherlands; 2010. p. 278-87.
55. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011;52:1212-7.
56. Beerepoot MA, Ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM et al. Lactobacilli vs. antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012;172:704-12.
57. Hull R, Rudy D, Donovan W, Svanborg C, Wieser I, Stewart C et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 2000;163:872-7. (Pubitemid 30091635)
58. Sunden F, Hakansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol 2010;184:179-85.
59. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol 2007;51:1534-40; discussion 40-1.
60. Damiano R, Quarto G, Bava I, Ucciero G, De Domenico R, Palumbo MI et al. Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol 2011;59:645-51.
61. Robert-Koch-Institut. Empfehlungen zur Prävention und Kontrolle Katheter-assoziierter Harnwegsinfektionen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 1999;42:806-9.
62. Piechota H, Pannek J. Katheterdrainage der Harnblase: Stand der Technik und Bedeutung für die Infektionsprävention. Hyg Med 2007;32:338-46.
63. Wagenlehner FME, Hoyme U, Kaase M, Fünfstück R, Naber KG, Schmiemann G. Clinical practice guideline: uncomplicated urinary tract infections. Dtsch Arztebl Int 2011;108:415-23.
64. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-63.